A review of the use of risk factor modification in the management of atherosclerotic arterial disease

ConclusionsBased on current knowledge, it appears that atherosclerosis is a multifactorial disease. There are differences in the effects of atherosclerotic risk factors between the various vascular beds. More than one risk factor is found in the majority of the patients and, often there is atherosclerotic involvement of several vascular territories. In order to prevent or retard atherosclerotic complications and improve patient survival, it is prudent that all the major modifiable risk factors should be corrected in patients with cardiovascular, cerebrovascular, and peripheral vascular disease.

[1]  F. Fowkes.  Epidemiology of Peripheral Vascular Disease , 2011, Springer London.

[2]  R. Bergström,et al.  Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. , 2009, Acta medica Scandinavica.

[3]  J. Cornhill,et al.  Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[4]  N. Santanello,et al.  Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: The dietary intervention study in children (DISC) , 1995 .

[5]  C. Hennekens,et al.  An overview of trials of cholesterol lowering and risk of stroke. , 1995, Archives of internal medicine.

[6]  Scandinavian Simvastatin Survival Study Group.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[7]  A. Gnasso,et al.  Common Carotid Arterial Wall Thickness in NIDDM Subjects , 1994, Diabetes Care.

[8]  C. Furberg,et al.  Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.

[9]  I. Holme,et al.  Influence of lipoprotein lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoprotein. , 1994, Atherosclerosis.

[10]  D. Agrawal,et al.  Cigarette smoking increases monocyte adherence to cultured endothelial cell monolayer. , 1994, Biochemical and biophysical research communications.

[11]  M. Laakso,et al.  Impact of Risk Factors on Limb Salvage After Angioplasty in Chronic Critical Lower Limb Ischemia , 1994, Angiology.

[12]  H. Lithell.  Pathogenesis and prevalence of atherosclerosis in hypertensive patients. , 1994, American journal of hypertension.

[13]  R. Natarajan,et al.  Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells , 1994, Journal of cellular physiology.

[14]  Stephen MacMahonf.  Cholesterol reduction and death from noncoronary causes: evidence from randomised controlled trials* , 1994 .

[15]  R. Simes,et al.  Low cholesterol and risk of non-coronary mortality. , 1994, Australian and New Zealand journal of medicine.

[16]  P. Durrington.  How HDL protects against atheroma , 1993, The Lancet.

[17]  L. Wilkins.  Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[18]  David C. Atkins,et al.  Cholesterol Reduction and the Risk for Stroke in Men , 1993, Annals of Internal Medicine.

[19]  F. Song,et al.  Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.

[20]  Jessica A. Mayer,et al.  Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. , 1993, Archives of internal medicine.

[21]  W. A. Bradley,et al.  Triglyceride, high density lipoprotein, and coronary heart disease. , 1993, Consensus statement. National Institutes of Health Consensus Development Conference.

[22]  J. Tyrrell,et al.  Lipoprotein [Lp(a)] and peripheral vascular disease , 1992, Journal of internal medicine.

[23]  J. Manson,et al.  The primary prevention of myocardial infarction. , 1992, The New England journal of medicine.

[24]  P. Sundaresan,et al.  Long‐term weight control study VII (weeks 0 to 210) , 1992, Clinical pharmacology and therapeutics.

[25]  Ncep Expert Panel on Blood Cholesterol Levels in Childr Adolescents.  National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. , 1992, Pediatrics.

[26]  H. Brien,et al.  A review of carotid endarterectomy at a large teaching hospital. , 1991, The American surgeon.

[27]  B. Dahlöf,et al.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) , 1991, The Lancet.

[28]  K. Radack,et al.  Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. , 1991, Archives of internal medicine.

[29]  M. Hennerici,et al.  Regression of carotid plaques during low density lipoprotein cholesterol elimination. , 1991, Stroke.

[30]  A. Folsom,et al.  Trends in Prevalence of Diabetes Mellitus in Patients with Myocardial Infarction and Effect of Diabetes on Survival: The Minnesota Heart Survey , 1991, Diabetes Care.

[31]  J L Witztum,et al.  Lipoproteins and atherogenesis. Current concepts. , 1990, JAMA.

[32]  P. Sandercock,et al.  Preventing Stroke by the Modification of Risk Factors , 1990, Stroke.

[33]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[34]  J. Rapp,et al.  Basic data related to lipid abnormalities in peripheral vascular disease. , 1990, Annals of vascular surgery.

[35]  G A Colditz,et al.  A meta-analysis of physical activity in the prevention of coronary heart disease. , 1990, American journal of epidemiology.

[36]  J. Meyer,et al.  Diabetes Mellitus as a Risk Factor for Stroke , 1990, Southern medical journal.

[37]  P. Morris,et al.  Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. , 1990, European journal of vascular surgery.

[38]  T. O'donnell,et al.  Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. , 1990, Journal of vascular surgery.

[39]  B Rosner,et al.  A prospective study of obesity and risk of coronary heart disease in women. , 1990, The New England journal of medicine.

[40]  V. Froelicher,et al.  Scientific evidence of the value of cardiac rehabilitation services with emphasis on patients following myocardial infarction - Section I: Exercise conditioning component , 1990 .

[41]  J. Regensteiner,et al.  Benefit of exercise conditioning for patients with peripheral arterial disease. , 1990, Circulation.

[42]  A. Goldberg.  Aerobic and resistive exercise modify risk factors for coronary heart disease. , 1989, Medicine and science in sports and exercise.

[43]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[44]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[45]  C. McCollum,et al.  Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. , 1989, BMJ.

[46]  R. Prager,et al.  Effects of 8-Wk α-Glucosidase Inhibition on Metabolic Control, C-Peptide Secretion, Hepatic Glucose Output, and Peripheral Insulin Sensitivity in Poorly Controlled Type II Diabetic Patients , 1989, Diabetes Care.

[47]  O. Paul.  Background of the Prevention of Cardiovascular Disease: II. Arteriosclerosis, Hypertension, and Selected Risk Factors , 1989, Circulation.

[48]  F. Yatsu,et al.  Atherosclerosis: Current concepts on pathogenesis and interventional therapies , 1989, Annals of neurology.

[49]  E. Barrett-Connor,et al.  Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease. An analysis of risk factors. , 1989, American journal of epidemiology.

[50]  W. Kannel,et al.  Diabetes, Intermittent Claudication, and Risk of Cardiovascular Events: The Framingham Study , 1989, Diabetes.

[51]  G. Beevers,et al.  Meta-analysis of relation between cigarette smoking and stroke. , 1989, BMJ.

[52]  R. Heidel,et al.  Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. , 1989 .

[53]  J. Toole,et al.  Cigarette smoking cessation and extracranial carotid atherosclerosis. , 1989, JAMA.

[54]  R. Prosser,et al.  The effect of postoperative smoking on femoropopliteal bypass grafts , 1989, Annals of vascular surgery.

[55]  P. Wilson,et al.  The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. , 1988, JAMA.

[56]  R. Kronmal,et al.  Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. , 1988, The New England journal of medicine.

[57]  W. Whitehouse.  Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality: Jonason T, Bergstrom R. Acta Med Scand 1987;221:253–260 , 1988 .

[58]  W. Fry,et al.  Factors affecting the patency of infrainguinal bypass. , 1988, Journal of vascular surgery.

[59]  W. Browner,et al.  Risk factor modification after myocardial infarction. , 1988, Annals of internal medicine.

[60]  W. Willett,et al.  Cigarette smoking and risk of stroke in middle-aged women. , 1988, The New England journal of medicine.

[61]  R B D'Agostino,et al.  Cigarette smoking as a risk factor for stroke. The Framingham Study. , 1988, JAMA.

[62]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[63]  L Wilhelmsen,et al.  Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden. , 1987, JAMA.

[64]  G. Assmann,et al.  The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. , 1987, The American journal of cardiology.

[65]  M. Laakso,et al.  Diabetes and atherosclerosis: an epidemiologic view. , 1987, Diabetes/metabolism reviews.

[66]  G. Jürgens,et al.  Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. , 1987, Neurology.

[67]  B. Guy-grand,et al.  [Influence of the distribution of body fat on vascular risk]. , 1987, Presse medicale.

[68]  R. Beaglehole,et al.  Cigarette smoking and risk of premature stroke in men and women. , 1986, British medical journal.

[69]  J. Cullen,et al.  International control of smoking and the US experience. , 1986, Chest.

[70]  M. Kamboh,et al.  Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm). , 1986, Chest.

[71]  W. Kannel.  Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. , 1985, American heart journal.

[72]  J. Fielding.  Smoking: Health Effects and Control , 1985 .

[73]  W. Kannel,et al.  Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study , 1985, Journal of the American Geriatrics Society.

[74]  Roger A. Renfrew,et al.  Lipid Research Clinics Program. , 1984, JAMA.

[75]  W. Kannel,et al.  Declining cardiovascular mortality. , 1984, Circulation.

[76]  J. Glover,et al.  Seeding human arterial prostheses with mechanically derived endothelium. The detrimental effect of smoking. , 1984, Journal of vascular surgery.

[77]  D. Jacobs,et al.  Effects on blood lipids and body weight in high risk men of a practical exercise program. , 1983, Atherosclerosis.

[78]  R. L. Rogers,et al.  Cigarette smoking decreases cerebral blood flow suggesting increased risk for stroke. , 1983, JAMA.

[79]  B. Lewis,et al.  TREATMENT OF HYPERLIPIDAEMIA RETARDS PROGRESSION OF SYMPTOMATIC FEMORAL ATHEROSCLEROSIS A Randomised Controlled Trial , 1983, The Lancet.

[80]  S. Johansson,et al.  Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. , 1983, British heart journal.

[81]  T. Meade,et al.  HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITY , 1983, The Lancet.

[82]  W. J. Walker.  Changing U. S. life style and declining vascular mortality--a retrospective. , 1983, The New England journal of medicine.

[83]  K. Vranizan,et al.  The effects of running mileage and duration on plasma lipoprotein levels. , 1982, JAMA.

[84]  W. Hood,et al.  Reduction of coronary atherosclerosis by moderate conditioning exercise in monkeys on an atherogenic diet. , 1981, The New England journal of medicine.

[85]  R. Gayle,et al.  Composite grafts utilizing polytetrafluoroethylene-autogenous tissue for lower extremity arterial reconstructions. , 1981, Surgery.

[86]  M. Bihari-varga,et al.  Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease. The influence of various risk factors. , 1981, Atherosclerosis.

[87]  C. Poletti,et al.  Book ReviewDiagnosis and Nonsurgical Management of Chronic Pain , 1981 .

[88]  M. Kameyama,et al.  Lipoprotein Abnormalities in the Pathogenesis of Cerebral Infarction and Transient Ischemic Attack , 1981, Stroke.

[89]  C. Zarins,et al.  Subcritical arterial stenosis enhances distal atherosclerosis , 1981 .

[90]  W. Kannel,et al.  Some health benefits of physical activity. The Framingham Study. , 1979, Archives of internal medicine.

[91]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[92]  A. J. Day,et al.  Hypertension-accelerated atherogenesis in cholesterol-fed rabbits. , 1977, Atherosclerosis.

[93]  W. Hollander,et al.  Aggravation of Atherosclerosis by Hypertension in a Subhuman Primate Model with Coarctation of the Aorta , 1976, Circulation research.

[94]  I. Webster.  The Age‐Prevalence of Cardiovascular Abnormalities in Relation to the Aging of Special‐Sense Function , 1974, Journal of the American Geriatrics Society.

[95]  A. Keys,et al.  Coronary heart disease: overweight and obesity as risk factors. , 1972 .

[96]  W. Kannel,et al.  Blood pressure and risk of coronary heart disease: the Framingham study. , 1969, Diseases of the chest.

[97]  D. Watkin,et al.  POSTOPERATIVE WOUND INFECTION. , 1965, Lancet.

[98]  S. Glagov,et al.  Atherosclerosis of human aorta and its coronary and renal arteries. A consideration of some hemodynamic factors which may be related to the marked differences in atherosclerotic involvement of the coronary and renal arteries. , 1961, Archives of pathology.

[99]  Harris Hyman,et al.  Preventing , 1938 .

[100]  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. 1979. , 1997, JAMA.

[101]  R. Califf,et al.  Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. , 1995, Circulation.

[102]  S. MacMahon.  Cholesterol reduction and death from non-coronary causes: evidence from randomised controlled trials. , 1994, Australian and New Zealand journal of medicine.

[103]  The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) , 1993, Archives of internal medicine.

[104]  K Steenland,et al.  Passive smoking and the risk of heart disease. , 1992, JAMA.

[105]  M. Dalsing,et al.  Outcome predictors in selection of balloon angioplasty or surgery for peripheral arterial occlusive disease. Veterans Administration Cooperative Study No. 199. , 1991, Surgery.

[106]  A. Leon,et al.  Effects of exercise conditioning on physiologic precursors of coronary heart disease , 1991 .

[107]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[108]  F. Bühler,et al.  Impact of smoking on heart attacks, strokes, blood pressure control, drug dose, and quality of life aspects in the International Prospective Primary Prevention Study in Hypertension. , 1988, American heart journal.

[109]  C. Caspersen,et al.  Physical activity and the incidence of coronary heart disease. , 1987, Annual review of public health.

[110]  Kannel Wb.  Hypertension. Relationship with other risk factors. , 1986 .

[111]  W. Kannel.  Hypertension. Relationship with other risk factors. , 1986, Drugs.

[112]  The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. , 1984, JAMA.

[113]  L. Elveback,et al.  Transient ischemic attack and stroke in a community-based diabetic cohort. , 1983, Mayo Clinic proceedings.

[114]  Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group. , 1982, JAMA.

[115]  W. Kannel,et al.  Role of lipids and lipoprotein fractions in atherogenesis: the Framingham study. , 1981, Progress in lipid research.

[116]  F A Mathewson,et al.  Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. , 1977, The American journal of cardiology.

[117]  S. Garattini,et al.  Some aspects of the effect of nicotine on plasma FFA and tissue triglycerides. , 1972, Pharmacology.

[118]  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. , 1970, JAMA.